Home > Insider Trading > Filing (0001567619-23-000839)

Filing Details

Accession Number:: 0001567619-23-000839
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-11 18:26:21
Reporting Period:: 2023-01-09

Accepted Time:: 2023-01-11 18:26:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1640266	Voyager Therapeutics Inc.	VYGR	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587114	Ecor1 Capital, Llc	357 Tehama Street #3 San Francisco CA 94103		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-09	456,000	$7.67	4,297,907	No	4	S	Indirect	See Note 1
Common Stock	Disposition	2023-01-10	336,400	$8.05	3,961,507	No	4	S	Indirect	See Note 1
Common Stock	Disposition	2023-01-11	110,000	$8.50	3,851,507	No	4	S	Indirect	See Note 1

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Note 1
No	4	S	Indirect	See Note 1
No	4	S	Indirect	See Note 1

Footnotes

The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds, and Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests the
Qualified Fund sold 429,505 shares of the Common Stock sold in this transaction.
After this transaction, Qualified Fund directly owned 3,999,933 shares of Common Stock.
Qualified Fund sold 268,985 shares of the Common Stock sold in this transaction.
After this transaction, Qualified Fund directly owned 3,730,948 shares of Common Stock.
Qualified Fund sold 103,609 shares of the Common Stock sold in this transaction.
After this transaction, Qualified Fund directly owned 3,627,339 shares of Common Stock.